EUVIMEDEUVIMED entdecken
Crossref

Polyhedral Oligomeric Silsesquioxane‐Based Nanoparticles for Efficient Chemotherapy of Glioblastoma

Xiangyang Zhong, Gang Wei, Boyang Liu, Chenyang Wang, Juan Wang, Yong Lu, Wenguo Cui iD, Hongbo Guo

Small · 2023-05 · 19 (18)

DOI: 10.1002/smll.202207248 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Small, 2023-02. Verfasst von Xiangyang Zhong und 7 weiteren Autor:innen. Beteiligte Einrichtung: Neurosurgery Center, The National Key Clinical Specialty, The Engineering Technology Research Center of Education Ministry of China on Diagnosis and …. Hauptthemen laut MEDLINE: Glioblastoma, Nanoparticles. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 49 Literaturangaben. Gefördert von: National Natural Science Foundation of China, China Postdoctoral Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Glioblastoma (GBM) is the most common lethal brain tumor with dismal treatment outcomes and poor response to chemotherapy. As the regulatory center of cytogenetics and metabolism, most tumor chemotherapeutic molecules exert therapeutic effects in the nucleus. Nanodrugs showing the nuclear aggregation effect are expected to eliminate and fundamentally suppress tumor cells. In this study, a nanodrug delivery system based on polyhedral oligomeric silsesquioxane (POSS) is introduced to deliver drugs into the nuclei of GBM cells, effectively enhancing the therapeutic efficacy of chemotherapy. The nanoparticles are modified with folic acid and iRGD peptides molecules to improve their tumor cell targeting and uptake via receptor‐mediated endocytosis. Nuclear aggregation allows for the direct delivery of chemotherapeutic drug temozolomide (TMZ) to the tumor cell nuclei, resulting in more significant DNA damage and inhibition of tumor cell proliferation. Herein, TMZ‐loaded POSS nanoparticles can significantly improve the survival of GBM‐bearing mice. Therefore, the modified POSS nanoparticles may serve as a promising drug‐loaded delivery platform to improve chemotherapy outcomes in GBM patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GlioblastomaNanoparticlesMiceAnimalsCell Line, TumorTemozolomideDrug Delivery Systems

Stichwörter der Autor:innen

chemotherapyglioblastomanuclear aggregationpolyhedral oligomeric silsesquioxane

Substanzen

Temozolomide

Autor:innen und Institutionen

  • Neurosurgery Center, The National Key Clinical Specialty, The Engineering Technology Research Center of Education Ministry of China on Diagnosis and Treatment of Cerebrovascular Disease, Guangdong Provincial Key Laborat…
  • Department of Orthopaedics, Shanghai Key Laboratory for Prevention and Treatment of Bone and Joint Diseases, Shanghai Institute of Traumatology and Orthopaedics, Ruijin Hospital, Shanghai Jiao Tong University School of…
  • Department of Radiology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, P. R. China.

ORCID-Profile: Wenguo Cui

Förderung

  • National Natural Science Foundation of China
  • China Postdoctoral Science Foundation

Zitieren

APA

Zhong, X., Wei, G., Liu, B., Wang, C., Wang, J., Lu, Y., Cui, W., & Guo, H. (2023). Polyhedral Oligomeric Silsesquioxane‐Based Nanoparticles for Efficient Chemotherapy of Glioblastoma. Small, 19(18). https://doi.org/10.1002/smll.202207248

Vancouver

Zhong X, Wei G, Liu B, Wang C, Wang J, Lu Y, et al. Polyhedral Oligomeric Silsesquioxane‐Based Nanoparticles for Efficient Chemotherapy of Glioblastoma. Small. 2023;19(18). doi:10.1002/smll.202207248

BibTeX
@article{Zhong2023,
  author = {Zhong, Xiangyang and Wei, Gang and Liu, Boyang and Wang, Chenyang and Wang, Juan and Lu, Yong and Cui, Wenguo and Guo, Hongbo},
  title = {Polyhedral Oligomeric Silsesquioxane‐Based Nanoparticles for Efficient Chemotherapy of Glioblastoma},
  journal = {Small},
  year = {2023},
  volume = {19},
  number = {18},
  doi = {10.1002/smll.202207248}
}
Kostenlos starten →